ADVERTISEMENT

Healthcare Q3 Results Preview- Ipca, Divi's Labs To Outperform Healthcare Pack, Says Motilal Oswal; Here's Why

Healthcare Q3 Results Preview : Motilal Oswal lists Sun Pharma, Mankind Pharma, Max Healthcare,, and Ipca Labs as its top picks in the sector.

<div class="paragraphs"><p>The recent decline in rates is expected to enable more funding for clinical development initiatives, improving the outlook for CDMO companies.. (Source:&nbsp;Yeko Photo Studio for&nbsp;freepik)</p></div>
The recent decline in rates is expected to enable more funding for clinical development initiatives, improving the outlook for CDMO companies.. (Source: Yeko Photo Studio for freepik)
The prospects for Indian CDMO companies are improving due to a rise in proposals from innovative pharmaceutical companies to non-Chinese companies.
To continue reading this story
You must be an existing Premium User
OUR NEWSLETTERS
By signing up you agree to the Terms & Conditions of NDTV Profit